S158: final result of tki discontinuation trial with dasatinib for second attempt of treatment free remission after failing first attempt with imatinib: treatment-free remission accomplished by dasatinib
HemaSphere(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要